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Abstract 
Background: Pinoresinol is a high-value plant-derived lignan with multiple health supporting effects. Enantiomeri-
cally pure pinoresinol can be isolated from natural sources, but with low efficiency. Most chemical and biocatalytic 
approaches that have been described for the synthesis of pinoresinol furnish the racemic mixture. In this study we 
devised a three-step biocatalytic cascade for the production of enantiomerically pure pinoresinol from the cheap 
compound eugenol. Two consecutive oxidations of eugenol through vanillyl-alcohol oxidase and laccase are followed 
by kinetic resolution of racemic pinoresinol by enantiospecific pinoresinol reductases.
Results: The addition of the enantiospecific pinoresinol reductase from Arabidopsis thaliana for kinetic resolution of 
(±)-pinoresinol to an in vitro cascade involving the vanillyl-alcohol oxidase from Penicillium simplicissimum and the 
bacterial laccase CgL1 from Corynebacterium glutamicum resulted in increasing ee values for (+)-pinoresinol; however, 
an ee value of 34 % was achieved in the best case. The ee value could be increased up to ≥99 % by applying Escheri-
chia coli-based whole-cell biocatalysts. The optimized process operated in a one-pot “two-cell” sequential mode and 
yielded 876 µM (+)-pinoresinol with an ee value of 98 %. Switching the reductase to the enantiospecific pinoresinol 
lariciresinol reductase from Forsythia intermedia enabled the production of 610 µM (−)-pinoresinol with an ee value of 
97 %.
Conclusion: A new approach for the synthesis of enantiomerically pure (+)- and (−)-pinoresinol is described that 
combines three biotransformation steps in one pot. By switching the reductase in the last step, the whole-cell biocat-
alysts can be directed to produce either (+)- or (−)-pinoresinol. The products of the reductases’ activity, (−)-laricires-
inol and (−)-secoisolariciresinol, are valuable precursors that can also be applied for the synthesis of further lignans.
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Background
The phytoestrogen pinoresinol 3 consists of two mon-
olignol units and belongs to the class of lignans. Multi-
ple health supporting effects of pinoresinol 3 have been 
reported including prevention and/or treatment of can-
cer [1–3], hyperglycaemia [4], HIV [3], skin-pigmenta-
tion [5], microvascular damage [6], and fungal infections 
[7]. Besides that, pinoresinol 3 is a precursor of the mam-
malian lignans enterodiol and enterolactone, for which 
health supporting effects were also reported [8–10]. 
Additionally, pinoresinol 3 can be used as antifungal 
agent for the treatment of Fusarium head blight causing 
high mycotoxin levels in wheat [11].
Currently, pinoresinol 3 is mainly isolated from seeds, 
fruits, and vegetables with low efficiency, but sometimes 
with high enantiopurity [12–14]. For example, 15 kg per-
isperm of Sesamum indicum are required for isolation of 
162 mg enantiopure (+)-pinoresinol 3a, or 114 g Daphne 
odora for 20.6 mg (−)-pinoresinol 3b [12, 14].
Additionally, a number of chemical and enzymatic 
approaches for the synthesis of (±)-pinoresinol 3 have 
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been described. Generally, these synthetic approaches 
start from simple and abundant low-value compounds 
(for example methyl acetoacetate), but require multiple 
steps and intensive work-up [15]. Alternatively, the num-
ber of required steps can be reduced by the use of more 
complex, but rare and expensive starting compounds 
(for example coniferyl alcohol 2) [16]. The absence of 
an inexpensive production process and the large num-
ber of potential applications make pinoresinol 3 a high-
value compound with growing interest from an economic 
point of view.
Recently, we have described an in vitro two-step one-
pot biocatalytic route for the synthesis of (±)-pinoresinol 
3 starting from the inexpensive substrate eugenol 1 [17]. 
This one-pot cascade combines the vanillyl-alcohol oxi-
dase from Penicillium simplicissimum (PsVAO) that con-
verts eugenol 1 into the intermediate coniferyl alcohol 
2 and a bacterial laccase for oxidation of coniferyl alco-
hol 2 leading to (±)-pinoresinol 3. The best results were 
achieved with the laccase CgL1 from Corynebacterium 
glutamicum. In the present study we describe the imple-
mentation of this cascade into whole-cell biocatalysts and 
the addition of a third enzymatic step allowing the syn-
thesis of enantiopure (+)-pinoresinol 3a or (−)-pinores-
inol 3b.
Generally, two strategies are possible for the produc-
tion of enantiopure pinoresinol 3: (1) Addition of a 
dirigent protein, or (2) kinetic resolution of (±)-pinores-
inol 3. Lewis and colleagues demonstrated that dirigent 
proteins are responsible for enantioselective produc-
tion of pinoresinol 3 in plants [18, 19]. The mechanism 
of their action has not been elucidated in detail yet, but 
it is assumed that dirigent proteins capture the radicals 
of oxidized coniferyl alcohol 2 and give them a defined 
orientation for coupling [20]. Therefore, the application 
of dirigent proteins for selective oxidative phenol cou-
pling seems attractive, but is hampered by the fact that 
the expression levels achieved in recombinant hosts 
(e.g. Pichia pastoris, Solanum peruvianum, Drosophila 
melanogaster) are very low [21–23] and that their iso-
lation from natural sources is not feasible [24, 25]. Fur-
thermore, it has been described that the addition of 
dirigent proteins to in  vitro reactions for the synthesis 
of (+)-pinoresinol 3a from coniferyl alcohol 2 leads to 
improved ee values of maximum ~86 % [22, 23, 26].
We decided to use an enantiospecific enzyme for 
kinetic resolution of (±)-pinoresinol 3. Pinoresinol 
reductases (PrR) and pinoresinol lariciresinol reductases 
(PLR) are NADPH-dependent enzymes capable of reduc-
ing pinoresinol 3 to lariciresinol 4 [27, 28]. In a second 
step PLR can further reduce lariciresinol 4 to secoiso-
lariciresinol 5 [27]. Both, lariciresinol 4 and secoiso-
lariciresinol 5, are high-value compounds. Almost all 
PrRs and PLRs characterized so far originate from plants 
[27–32], except two PrRs that were discovered in sphin-
gomonads [33]. Some PrRs and PLRs were reported to 
display enantioselectivity: PrR from Arabidopsis thaliana 
(NCBI Reference Sequence: NP_193102.1; AtPrR2) con-
verts preferably (−)-pinoresinol 3b to (−)-lariciresinol 
4b [28], while PLR from Forsythia intermedia (GenBank 
AAC49608; FiPLR) reduces preferably (+)-pinoresinol 
3a to (+)-lariciresinol 4a [and further to (−)-secoi-
solariciresinol 5a] [27]. In this work we investigated 
the potential of kinetic resolution for the enrichment 
of enantiopure (+)-pinoresinol 3a by AtPrR2 and 
(−)-pinoresinol 3b by FiPLR. This step was incorporated 
into a one-pot three-step synthesis starting from the 
inexpensive substrate eugenol 1 (Scheme 1).
Results and discussion
Expression of reductases
The genes syatprr2 and syfiplr coding for the reduc-
tases AtPrR2 and FiPLR, respectively, were cloned and 
expressed in recombinant Escherichia coli. In order to 
achieve high expression levels of the reductases, codon 
optimized genes (see Additional file 1) were used, and the 
expression in several E. coli strains was compared (Fig. 1).
SDS-PAGE and Western-Blot revealed that both reduc-
tases could be expressed in a soluble form (Fig. 1). Activ-
ity assays with pinoresinol 3 (see “Methods” section) 
demonstrated that the highest conversions were achieved 
when the soluble protein fractions (cleared cell lysates) 
after the heterologous expressions of AtPrR2 and FiPLR 
in E.  coli strains C41(DE3) or C43(DE3) were deployed 
(see Additional file 2).
In vitro one‑pot three‑step cascade reaction for the 
synthesis of enantiopure pinoresinol
In a first trial to synthesize enantiopure pinoresinol 3, the 
vanillyl-alcohol oxidase PsVAO and the bacterial laccase 
CgL1 used in the previously established one-pot cascade 
were combined with AtPrR2 from A. thaliana and tested 
in vitro under the conditions best suited for the first two 
bioconversion steps [17]. Unexpectedly, no reduction of 
(−)-pinoresinol 3b to (−)-lariciresinol 4b was observed 
under these conditions (ee = 0 %; data not shown). Also 
a sequential reaction set-up (addition of AtPrR2 to the 
PsVAO-CgL1 cascade after 22 h) resulted only in a minor 
conversion of (−)-pinoresinol 3b; the achieved ee value of 
the remaining (+)-pinoresinol 3a was 34 %. A prolonged 
reaction time did not lead to increased ee values. As tert-
butylmethylester (tBME) was added to the previously 
established PsVAO-CgL1 cascade to enhance the yield of 
(±)-pinoresinol 3, we supposed that this organic solvent 
could negatively affect AtPrR2 activity. Indeed, when we 
set up the activity assay for conversion of pinoresinol 3 by 
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AtPrR2 in the presence of tBME, the pinoresinol 3 con-
version was decreased (53 % with tBME vs 98 % without 
tBME), which allows the assumption that AtPrR2 is not 
stable in the presence of this organic solvent. In addi-
tion, it was found that the presence of eugenol 1 also 
negatively affects the conversion of pinoresinol 3 by 
AtPrR2 (only 60 % conversion). Obviously, the use of the 
selected isolated enzymes in an in vitro one-pot mode is 




































































Scheme 1 Synthesis of enantiopure pinoresinol 3 by a three-step cascade reaction. The one-pot synthesis combines PsVAO, a bacterial laccase, 
and an enantiospecific pinoresinol reductase
Fig. 1 SDS-PAGE and Western-Blot analysis of reductase gene expressions in different E. coli strains. a Expression of syatprr2 with C-terminal 
His6-tag; b expression of syfiplr with C-terminal His6-tag; c expression of syfiplr without His6-tag. 1 E. coli BL21(DE3) cells before induction, 2 
E. coli BL21(DE3) cells 6 h, 3 E. coli BL21(DE3) cells 24 h, 4 E. coli C41(DE3) cells 6 h, 5 E. coli C41(DE3) cells 24 h, 6 E. coli C43(DE3) cells 6 h, 7 E. coli 
C43(DE3) cells 24 h, 8 E. coli SHuffle T7 Express cells 6 h, 9 E. coli SHuffle T7 Express cells 24 h, M Molecular weight marker
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Laccase screening for establishment of whole‑cell 
biocatalysts
Based on these results, in the next set of experiments 
the focus was shifted to the design of whole-cell biocat-
alysts. Besides enhancing enzyme stability, whole cells 
provide the advantage that the cofactor for the NADPH-
dependent reductases is regenerated through the cell 
metabolism. For the construction of E.  coli whole-cell 
biocatalysts, the strain C41(DE3) was chosen due to the 
high expression levels (and thus resulting in high activi-
ties) of AtPrR2  and FiPLR (Additional file  2), as well as 
PsVAO (data not shown).
Our previous results demonstrated that an adjustment 
of PsVAO and bacterial laccase activities was essential 
for increasing the yield of (±)-pinoresinol 3 in vitro [17]. 
Therefore, in a first step, the most suitable laccase for 
the conversion of coniferyl alcohol 2 in the in vivo pro-
cess had to be identified. Resting E. coli cells expressing 
PsVAO and one of the three bacterial laccases (CotA from 
Bacillus licheniformis, Ssl1 from Streptomyces sviceus or 
CgL1 from Corynebacterium glutamicum) were tested for 
the conversion of 10  mM eugenol 1 to (±)-pinoresinol 
3. For the co-expression of PsVAO and CotA almost no 
formation of (±)-pinoresinol 3 was observed, although 
eugenol 1 and the intermediate coniferyl alcohol 2 were 
converted completely. During co-expression of PsVAO 
and Ssl1 the formation of (±)-pinoresinol 3 reached 
550  µM after 4  h and decreased thereafter. The highest 
yield of (±)-pinoresinol 3 of 1.2 mM was achieved with 
E. coli cells co-expressing PsVAO and CgL1 (Fig. 2). The 
low yields of (±)-pinoresinol 3 in the reactions contain-
ing CotA or Ssl1 can presumably be explained by the fur-
ther oxidation of (±)-pinoresinol 3 by these laccases [17]. 
Higher expression levels of CotA (3400  mU  ml−1) and 
Ssl1 (900 mU ml−1) compared to CgL1 (177 mU ml−1), as 
well as higher redox potentials of CotA and Ssl1 result in 
faster oxidation of (±)-pinoresinol 3 [17].
In vivo one‑pot “one‑cell” cascade reaction for the 
synthesis of enantiopure (+)‑pinoresinol
In a first trial all enzymes (PsVAO, CgL1, and AtPrR2) 
were co-expressed in the E.  coli strain C41(DE3) to fur-
nish enantiopure (+)-pinoresinol 3a by a whole-cell bio-
catalyst. The cells were harvested after enzyme expression, 
resuspended in 50 mM potassium phosphate (KPi)-buffer, 
pH  7.5, and supplemented with eugenol 1. The addition 
of 1  mM or 2.5  mM eugenol 1 yielded (+)-pinoresinol 
3a with ee values of 74 and 88  %, respectively (Table  1, 
entries  1, 2), whereas with 10  mM of eugenol 1 the ee 
value reached only 4 % (Table 1, entry 3). In search of an 
explanation for the decreased ee value at a high concentra-
tion of eugenol 1, it was found that eugenol 1 had previ-
ously been described to be toxic for E. coli [34, 35]. Indeed, 
cell growth analysis in the presence of different concentra-
tions of eugenol 1 (1, 2.5, 5, or 10 mM) revealed that con-
centrations of eugenol 1 above 5 mM were highly toxic (no 
further cell growth was observed; see Additional file  3). 
The addition of 2.5  mM eugenol 1 reduced cell growth 
by about 70 %, whereas 1 mM eugenol 1 had the slightest 
effect on cell growth (25  % reduced OD600 compared to 
control reaction without eugenol 1). In addition, cell via-
bility tests with resting E. coli cells revealed that eugenol 1 
concentrations of 10 mM were highly toxic and led to cell 
lysis (Fig. 3). Upon cell lysis AtPrR2 gets exposed to high 
concentrations of eugenol 1 and additionally the cofactor 
regeneration by the cell metabolism is no longer assured, 
which presumably explains the loss of its function. 
To circumvent the limitation of substrate toxicity, a 
step-wise addition of eugenol 1 was applied to the “one-
cell” system with resting E. coli cells harbouring all three 
enzymes (PsVAO, CgL1, and AtPrR2) (Fig. 4a). The cells 
were first supplemented with low concentrations of euge-
nol 1 (1 or 2.5  mM) and incubated for 1  h. After that, 
doses of 1 or 2.5 mM of eugenol 1 were added every 1 h 
for a time period of 9 h. Compared to the initial experi-
ments with 10  mM of eugenol 1 added at once, the ee 
value could be increased up to 37 % (Table 1, entries 4, 5). 
A slower addition of 1 mM eugenol 1 every 2 h (Table 1, 
entry 6) or every 4 h (Table 1, entry 7) resulted in ee val-
ues of 44   and ≥99  %, respectively, but the concentra-
tions of (+)-pinoresinol 3a achieved were lower (190 and 
63 µM, respectively). In all cases, the obtained ee values 
were in accordance with the observed cell viability; they 
were increasing with increasing viability of the cells, 
which points out the importance that intact cells are 
required in order to achieve high AtPrR2 activity.
Fig. 2 Achieved concentrations of (±)-pinoresinol 3 in whole-cell 
biotransformations combining PsVAO and a bacterial laccase (CotA, 
Ssl1, or CgL1). Reaction conditions: 10 mM eugenol 1, 70 g l−1 cww 
E. coli C41(DE3) harbouring PsVAO and a bacterial laccase, resus-
pended in 50 mM KPi-buffer, pH 7.5, 0.1 mM IPTG
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We observed that during the course of the reaction, 
formation of a side product occured that we identified as 
coniferyl aldehyde 6. This side reaction could not be attrib-
uted to any of the enzymes of the cascade. To understand 
the origin of coniferyl aldehyde 6, control reactions were 
performed with resting E.  coli cells that did not express 
heterologous enzymes but were supplemented with euge-
nol 1, coniferyl alcohol 2, or pinoresinol 3. While no con-
version of eugenol 1 and pinoresinol 3 was seen, coniferyl 
alcohol 2 was oxidized by the E. coli cells to coniferyl alde-
hyde 6. Presumably, coniferyl alcohol 2 is used to regener-
ate NADPH due to a shifted NADPH/NADP+ equilibrium 
towards NADP+ within the cell. To prove this hypothesis, 
either 25 g  l−1 glycerol or 20 g  l−1 d-glucose were added 
to E. coli cells harbouring PsVAO and CgL1 as an energy 
source to ensure higher NADPH concentrations. As 
expected, conversion of 2.5 mM eugenol 1 with addition of 
glycerol or d-glucose resulted in higher concentrations of 
(±)-pinoresinol 3 (351 and 375 µM, compared to 153 µM; 
Table 2) and reduced coniferyl aldehyde 6 formation (see 
Additional file 4).
When the same reaction set-up was assigned to E. coli 
cells harbouring PsVAO, CgL1, and AtPrR2, similar 
amounts of (±)-pinoresinol 3 were detected (308 and 
402 µM), but unexpectedly no conversion of (−)-pinores-
inol 3b to (−)-lariciresinol 4b was obtained (ee  %  =  2 
and 0; Table 2). We speculate that due to reduced forma-
tion of coniferyl aldehyde 6 under these conditions the 
accumulation of higher concentrations of coniferyl alco-
hol 2 could either be toxic for the cells and/or negatively 
Table 1 Concentrations of pinoresinol 3 and corresponding ee values achieved in the three-step one-pot system
All reaction conditions tested yielded 100 % conversion of eugenol 1
a Reaction conditions: reaction buffer (50 mM KPi-buffer, pH 7.5, 100 µM IPTG), 2 % (v/v) dimethyl sulfoxide (DMSO), concentrations of eugenol 1 as indicated. 
Reactions were carried out for 24 h at 25 °C, 140 rpm 
b Recombinant E. coli C41(DE3) harbouring PsVAO, CgL1, and AtPrR2 resuspended in 10 ml reaction buffer with an adjusted cell wet weight (cww) of 70 g l−1
c Recombinant E. coli C41(DE3) harbouring PsVAO and CgL1 resuspended in 10 ml reaction buffer with 20 g l−1 d-glucose (cww adjusted to 70 g l−1)
d Without addition of recombinant E. coli cells harbouring AtPrR2 or FiPLR
e Addition of recombinant E. coli cells harbouring AtPrR2 or FiPLR resuspended in 10 ml reaction buffer with 20 g l−1 d-glucose (cww adjusted to 70 g l−1) after 24 h; 
further incubation for 4 h
f As reaction e, but further incubation for 8 h
g As reaction e, but further incubation for 2 h
h As reaction e, but further incubation for 6 h
Entry Added concentration of 1a Addition of Concentration of 3 (µM) ee value (%)
1 1 x 1 mMb – 6 ± 5 74 [(+)-3a]
2 1 x 2.5 mMb – 32 ± 8 88 [(+)-3a]
3 1 x 10 mMb – 995 ± 119 4 [(+)-3a]
4 10 x 2.5 mMb 1 every 1 h 2730 ± 10 25 [(+)-3a]
5 10 x 1 mMb 1 every 1 h 1030 ± 70 37 [(+)-3a]
6 5 x 1 mMb 1 every 2 h 190 ± 20 44 [(+)-3a]
7 3 x 1 mMb 1 every 4 h 63 ± 9 ≥99 [(+)-3a]
8 1 x 10 mMc,d – 1472 ± 16 1 [(+)-3a]
9 1 x 10 mMc,e C41AtPrR2 822 ± 44 97 [(+)-3a]
10 1 x 10 mMc,f C41AtPrR2 876 ± 21 98 [(+)-3a]
11 1 x 10 mMc,g C41FiPLR 610 ± 19 97 [(−)-3b]
12 1 x 10 mMc,e C41FiPLR 456 ± 19 95 [(−)-3b]
13 1 x 10 mMc,h C41FiPLR 434 ± 40 92 [(−)-3b]
Fig. 3 Cell viability of resting E. coli cells harbouring PsVAO, CgL1, and 
AtPrR2 after incubation for 24 h. The influence of different concentra-
tions of eugenol 1 is shown. a Addition of eugenol 1 in one step; b 
stepwise addition of eugenol 1 as indicated. Data are plotted in rela-
tion to the amount of living cells at t = 0 h that was set as 100 %
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affect the activity of AtPrR2 (as was observed for eugenol 
1), but this was not investigated in detail.
In vivo one‑pot “two‑cell” sequential cascade reaction 
for the synthesis of enantiopure (+)‑pinoresinol
Because of the correlation between cell viability and AtPrR2 
activity, and the observation that higher concentrations of 
(±)-pinoresinol 3 were achieved in the presence of d-glu-
cose, we decided to separate the kinetic resolution step of 
(±)-pinoresinol 3 from its production step. The one-pot 
approach was set up in a sequential mode of operation 
(Fig. 4b) as follows: High concentrations of eugenol 1 were 
added to a first set of resting E. coli cells harbouring PsVAO 
and CgL1, but not AtPrR2. The first two biocatalytic steps 
of this cascade are independent from cofactors, and PsVAO 
and CgL1 are stable in the presence of high concentra-
tions of eugenol 1; therefore cell lysis due to substrate tox-
icity does not affect the production of (±)-pinoresinol 3. 
After 24 h freshly prepared resting E. coli cells harbouring 
AtPrR2 were added to the reaction and continued for addi-
tional 4–8 h. Under these conditions, at 10 mM of eugenol 
1, up to 876 µM (+)-pinoresinol 3a with an ee value of 98 % 
Fig. 4 Two optimization approaches for the synthesis of enantiopure pinoresinol 3. a Stepwise addition of 1 or 2.5 mM eugenol 1 to resting E. coli 
cells harbouring PsVAO, CgL1, and AtPrR2; b addition of 10 mM eugenol 1 in a one-pot “two-cell” sequential mode of operation: The substrate was 
added to resting E. coli cells harbouring PsVAO and CgL1. After 24 h resting E. coli cells harbouring AtPrR2 were added. Intensity of yellow colour 
indicates eugenol 1 concentration in the reaction
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were gained (Table 1, entries 9, 10). The maximal theoretical 
molar yield of enantiopure pinoresinol 3 starting from euge-
nol 1 is 25 %. In comparison, we achieved 8.8 % which cor-
responds to one third of the maximal yield. This difference 
can be explained through side product formation due to the 
radical reaction mechanism of laccases, as described previ-
ously [17, 23]. As a consequence, 1472 µM (±)-pinoresinol 
3 were achieved starting from 10 mM eugenol 1 at almost 
complete conversion of substrate 1 and intermediate 2.
Encouraged by these results an upscaling experiment 
was performed: 160 mg eugenol 1 (10 mM, 0.98 mmol) 
were added to 100  ml  resting E.  coli cells harbouring 
PsVAO and CgL1 (resuspended in reaction buffer; see 
“Methods” section). After 24 h 100 ml resting E. coli cells 
harbouring AtPrR2 were added and the reaction was con-
tinued for additional 4 h. Enantiopure (+)-pinoresinol 3a 
(see Additional file 5A) and (−)-lariciresinol 4b (which is 
not commercially available) were purified from the reac-
tion, and isolated yields of 12 % (19 mg) and 11 % (18 mg) 
were achieved, respectively.
In vivo one‑pot “two‑cell” sequential cascade reaction 
for the synthesis of enantiopure (−)‑pinoresinol
Besides the production of (+)-pinoresinol 3a, we inves-
tigated the potential of the one-pot “two-cell” system for 
the production of enantiopure (−)-pinoresinol 3b. This 
compound is not commercially available and its effective 
production is particularly attractive. E. coli cells harbour-
ing FiPLR from F. intermedia with an opposite enantiose-
lectivity to AtPrR2 were applied for the kinetic resolution 
step. Utilizing this set-up under the established reac-
tion conditions, the concentrations of (−)-pinoresinol 
3b achieved 610  µM with an ee value of 97  % (Table  1, 
entries 11–13), which is in a similar range compared to 
the system producing (+)-pinoresinol 3a. Moreover, the 
high-value compound (−)-secoisolariciresinol 5a was 
formed with an ee value of ≥99  % through the further 
oxidation of (+)-lariciresinol 4a by FiPLR (see Additional 
file 5B).
Conclusions
Within this study, we demonstrated that the three-step 
cascade including a kinetic resolution step is a power-
ful approach for the synthesis of enantiopure pinores-
inol 3 starting from the inexpensive substrate eugenol 
1. A sequentially operating one-pot “two-cell” process 
is preferable to a simultaneous one-pot “one-cell” mode 
of operation. It was demonstrated that the process 
could easily be switched from production of enantio-
pure (+)-pinoresinol 3a to enantiopure (−)-pinoresinol 
3b by choosing a plant reductase with opposite 
enantioselectivity.
In addition, the high-value compound (−)-lariciresinol 
4b was isolated in enantiopure form, and the formation 
of enantiopure (−)-secoisolariciresinol 5a was demon-
strated. This enables the development of biocatalytic 
systems for the production of lariciresinol 4 and secoi-
solariciresinol 5 that can serve as building blocks for the 
production of other lignans.
Methods
Enzymes and chemicals
Pinoresinol 3 (≥95  %, SML0073; mixture composed of 
61 % 3a and 39 % 3b), (+)-lariciresinol 4a (≥95 %, 06892), 
and secoisolariciresinol 5 (≥95 %, 60,372) were obtained 
in HPLC grade from Sigma-Aldrich. All other chemicals 
were purchased in an analytical or higher grade from 
Sigma-Aldrich, Alfa Aesar, or Merck. LC/MS grade sol-
vents were from Sigma-Aldrich (water) and Fisher Sci-
entific (formic acid and methanol). HPLC grade solvents 
were obtained from Carl Roth (n-heptane), Th. Geyer 
(n-hexane), and Sigma-Aldrich (ethanol). Enzymes for 
molecular biology (DNA-polymerase, restriction endo-
nucleases, T4-DNA-ligase) were acquired from Thermo 
Scientific. “Anti-His6-Peroxidase  (2)” and the “BM Blue 
POD Substrate (precipitating)” from Roche were used for 
Western-Blot analysis.
Synthetic genes and molecular biology
Synthetic genes
Synthetic genes syatprr2 and syfiplr (see Additional file 1) 
were ordered codon optimized for E. coli from Eurofins 
MWG Operon. A C-terminal hexa-histidine tag (His6-
tag) was added to the sequence of syfiplr.
Cloning of reductase genes
The genes syatprr2 and syfiplr were amplified by poly-
merase chain reaction (PCR) using the synthetic genes 
as template and the oligonucleotide sequences (Eurofins 
Table 2 Achieved concentration of  pinoresinol 3 and  ee 
values for (+)-3a in the one-pot “one-cell” set-up depend-
ing on the energy source added
All reactions yielded 100 % conversion of eugenol 1
Reaction conditions: recombinant E. coli cells resuspended in 10 ml 50 mM KPi-
buffer, pH 7.5, 100 µM IPTG (cww = 70 g l−1); 2 % (v/v) DMSO; 2.5 mM of eugenol 
1. Reactions were carried out for 24 h at 25 °C, 140 rpm 







ing PsVAO and 
CgL1
None added 153 ± 40.7 4
25 g l−1 glycerol 351 ± 27 8
20 g l−1 d-glucose 375 ± 17 5
C41(DE3) harbour-
ing PsVAO and 
CgL1 and AtPrR2
None added 42 ± 3 ≥99
25 g l−1 glycerol 308 ± 29 2
20 g l−1 d-glucose 402 ± 28 0
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MWG Operon) listed in Table 3. The restrictions sites of 
the endonucleases NdeI and XhoI are underlined, and the 
His6-tag sequence is marked in bold.
The amplified DNA fragments and the plasmid 
pCDF-Duet were cut with NdeI and XhoI and ligated 
by T4-DNA-ligase resulting in the expression plasmids 
pCDF-Duet_syatprr2_his6, pCDF-Duet_syfiplr_his6, and 
pCDF-Duet_syfiplr. Correct insertion was verified by 
Sanger DNA sequencing (GATC Biotech).
Cloning of psvao and co‑expression plasmids
For whole-cell biotransformations different plasmids for 
the co-expression of certain genes were produced (see 
Additional file  1): (1) pACYCtac_psvao, (2) pCDF-Duet_
psvao_syatprr2_his6, (3) pCDF-Duet_psvao_syfiplr.
First, the gene psvao was inserted into the plasmid 
pACYCtac (kindly provided by Dr. Natalie Trachtmann, 
Institute of Microbiology, University of Stuttgart). Ampli-
fication by PCR took place using pET28b_psvao [17] as 
template and the oligonucleotides 5′-AACGAGCTCG 
ATGTCCAAGACACAGG-3′ and 5′-CCCAAGCTTG 
GGTTACAGTTTCC-3′. Restriction of the amplified 
DNA fragments and pACYCtac was done with the restric-
tion endonucleases SacI and HindIII.
Next, psvao was also cloned upstream of reductase 
genes into the first multiple cloning site (MCS) of the 
pCDF-Duet-based expression plasmids generated before. 
Psvao was cut out of pACYCtac_psvao with SacI and 
HindIII and ligated into the plasmids pCDF-Duet_syat-
prr2_his6 or pCDF-Duet_syfiplr. After ligation the result-
ing plasmids were confirmed by Sanger DNA sequencing 
(GATC Biotech).
Heterologous expression in E. coli
For heterologous expression of genes (syatprr2, syfiplr, 
psvao) different E.  coli strains were tested: BL21(DE3), 
OverExpress C41(DE3), OverExpress C43(DE3), and 
Shuffle T7 Express. 5 ml LB medium supplemented with 
50 µg ml−1 streptomycin (syatprr2, syfiplr), or 34 µg ml−1 
chloramphenicol (psvao), were inoculated with a sin-
gle colony and incubated over night at 37  °C, 180  rpm. 
Expression was performed in 50 ml TB-medium with the 
corresponding antibiotic inoculated with 500  µl of the 
pre-culture and incubated at 37 °C, 180 rpm to an optical 
density at 600 nm (OD600) of 0.6. 0.5 mM isopropyl β-D-
1-thiogalactopyranoside (IPTG) was added to the cul-
ture and thereafter incubated at 30 °C, 140 rpm for 21 h. 
The culture was harvested by centrifugation at 3200×g 
and resuspended in 5 ml 50 mM KPi-buffer, pH 7.5 with 
0.1 mM phenylmethylsulfonyl fluoride (PMSF). Cell lysis 
was performed by sonication on ice, and cell debris was 
removed by centrifugation at 11,325×g for 20 min.
Expressions of the laccase gene cgl1 from Corynebac-
terium glutamicum [36] and the glucose dehydrogenase 
(GDH) gene gdhIV from Bacillus megaterium [37] were 
performed as described previously.
Determination of enzymatic activities
Activity assay for reductases
The activities of the soluble protein fractions of reduc-
tase expressions were analysed towards pinoresinol 3 in 
a reaction volume of 500 µl. 50 µl soluble protein fraction 
was added to 200 µM pinoresinol 3 and 200 µM NADPH 
in 50 mM KPi-buffer, pH 7.5 and incubated at 25 °C for 
16 h. Optionally, a cofactor regeneration system consist-
ing of 20 mM d-glucose and 3 U ml−1 GDH was added.
For LC/MS analysis 100  µM ferulic acid methyl ester 
[FSME; 5  mM stock solution in dimethyl sulfoxide 
(DMSO)] was added as internal standard and the reac-
tion was extracted with 600 µl ethyl acetate. The organic 
phase was evaporated and the residue was resuspended 
in 100 µl methanol. Non-chiral LC/MS analysis was per-
formed as described below.
The influence of eugenol 1 and tBME on the reduc-
tase activity was tested as follows: eugenol 1 (1, 2.5, or 
10  mM) or 20  % (v/v) tBME were added to the estab-
lished activity assay, and the reactions were performed 
and analysed by non-chiral LC/MS as described.
Table 3 Oligonucleotides used for polymerase chain reaction 
Gene Oligonucleotide
Name Sequence
syatprr2 (with His6-tag) syatprr2_tag_fw 5′-GGGTTTCATATGAAAGAGACTAACTTCGGCG-3′
syatprr2_tag_rev 5′-CCGCTCGAGTCAGTGGTGATGATGGTGATGACCGCCGACGAAAATTTTCAG-3′
syfiplr (with His6-tag) syfiplr_tag_fw 5′-GGGTTTCATATGGGCAAATCCAAAGTTCTG-3′
syfiplr_tag_rev 5′-CCGCTCGAGTCAGTGGTGATGATGG-3′
syfiplr (no tag) syfiplr_fw 5′-GGGTTTCATATGGGCAAATCCAAAGTTCTG-3′
syfiplr_rev 5′-CCGCTCGAGTCAAACATAGCGTTTAAGGTATTCTTCAAC-3′
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Activity assays for PsVAO and CgL1
The activities of PsVAO and CgL1 were determined as 
described previously [17].
In vitro one‑pot three‑step cascade reaction for the 
synthesis of enantiopure pinoresinol
The reaction for the synthesis of enantiopure (+)-pinores-
inol 3a was set up by addition of the reductase AtPrR2 to 
the previously established in vitro cascade reaction [17]. 
1 mM eugenol 1 in 50 mM KPi-buffer, pH 7.5 was sup-
plemented with 20  % (v/v) tBME, 10  mU  ml−1 PsVAO, 
50  mU  ml−1 CgL1, 0.03  mU  ml−1 AtPrR2, 200  µM 
NADPH, 20 mM d-glucose, and 3 U ml−1 GDH. Samples 
were incubated at 25 °C for 7.5 h in an overhead shaker 
(20 rpm).
For GC/MS analysis 100  µM FSME was added, and 
extraction was performed twice with 300 µl ethyl acetate. 
All samples were analysed by GC/MS and non-chiral LC/
MS as described below.
Laccase screening
For whole-cell biotransformations of eugenol 1 com-
binations of PsVAO and different bacterial laccases 
(CotA, Ssl1, or CgL1) were analysed. E. coli OverExpress 
C41(DE3) was chosen due to high expression levels of the 
recombinant enzymes.
Competent C41(DE3) cells were co-transformed 
with the following plasmids: (1) pACYCtac_psvao and 
pETK316 N/D500G, (2) pACYCtac_psvao and pET22ssl1, 
or (3) pACYCtac_psvao and pET16b_cgl1 (see Addi-
tional file  1). Expressions were carried out in 200  ml 
TB-medium supplemented with 100  µg  ml−1 ampicillin 
and 34  µg  ml−1 chloramphenicol at 37  °C, 180  rpm. At 
an OD600 of 0.6 0.5 mM IPTG and CuSO4 (2 mM in case 
of CotA and Ssl1, 3  mM in case of CgL1) were added. 
Thereafter, cultures were incubated at 30 °C, 140 rpm for 
21 h.
Cells were harvested by centrifugation and resus-
pended in reaction buffer (50  mM KPi, pH  7.5; 100  µM 
IPTG) thereby adjusting a cell wet weight of 70 g l−1 (cor-
responding to 18.1 g l−1 cell dry weight). 10 ml of resus-
pended cells were exposed to 10 mM eugenol 1 and 2 % 
(v/v) DMSO and incubated at 25 °C, 140 rpm in an orbital 
shaker for 24  h. Samples (0.5  ml) were taken after cer-
tain time points, 2 mM FSME (100 mM stock solution in 
DMSO) was added and extracted with 1 ml ethyl acetate. 
All samples were analysed by GC/MS as described below.
In vivo one‑pot “one‑cell” cascade reaction for synthesis 
of enantiopure pinoresinol
E.  coli OverExpress C41(DE3) cells co-expressing the 
plasmids pCDF-Duet_psvao_systprr2_his6 and pET16b_
cgl1 were employed. Protein expression and adjustment 
of cell wet weight was conducted as described above for 
the co-expression of PsVAO and a bacterial laccase.
The one-pot “one-cell” cascade was analysed regard-
ing (1) different eugenol 1 concentrations (1–10 mM), (2) 
addition of different energy sources (20 g l−1 d-glucose or 
25 g l−1 glycerol), and (3) the stepwise addition of euge-
nol 1 (1 mM or 2.5 mM added as indicated in Table 1).
Control reactions were performed in the same manner 
but with E. coli cells not expressing heterologous genes; 
1 mM eugenol 1, 1 mM coniferyl alcohol 2, or 0.75 mM 
pinoresinol 3 were added to the cells.
Extraction was performed with 6 ml ethyl acetate after 
addition of 100 µM FSME (for concentrations of eugenol 
1 of up to 3 mM) or 2 mM FMSE (in all other cases). All 
samples were analysed by CG/MS, non-chiral LC/MS, 
and chiral HPLC as described below.
In vivo one‑pot “two‑cell” sequential cascade reactions 
for synthesis of enantiopure pinoresinol
The one-pot “two-cell” sequential reaction was realized 
by employing two types of cells: Conversion of eugenol 1 
to (±)-pinoresinol 3 was achieved by E. coli OverExpress 
C41(DE3) cells carrying plasmids pACYCtac_psvao and 
pET16b_cgl1, whereas kinetic resolution of (±)-pinores-
inol 3 was done by E.  coli OverExpress C41(DE3) cells 
carrying either pCDF-Duet_syatprr2_his6 (for synthesis 
of (+)-pinoresinol 3a), or pCDF-Duet_syfiplr (for syn-
thesis of (−)-pinoresinol 3b). Protein expression was 
conducted as described above for the co-expression of 
PsVAO and a bacterial laccase.
The first step of the reaction was performed with rest-
ing E.  coli cells with heterologously expressed PsVAO 
and CgL1 (resuspended in 10 ml reaction buffer supple-
mented with 25 g l−1 d-glucose; cell wet weight adjusted 
to 70  g  l−1), 2  % (v/v) DMSO, 10  mM eugenol 1. After 
24  h resting E.  coli cells with heterologously expressed 
AtPrR2 or FiPLR were added (resuspended in 10 ml reac-
tion buffer supplemented with 25 g l−1 d-glucose; cell wet 
weight adjusted to 70  g  l−1). Extraction was performed 
with 6 ml ethyl acetate after addition of 2 mM FMSE. All 
samples were analysed by GC/MS, non-chiral LC/MS, 
and chiral HPLC as described below.
For scale-up experiments, the reaction was multiplied 
by the factor of 10 resulting in a substrate amount of 
160 mg (10 mM in 100 ml), 100 ml E. coli cells harbour-
ing PsVAO and CgL1, and 100 ml E. coli cells harbouring 
AtPrR2.
Pinoresinol 3 and lariciresinol 4 were purified from 
the reaction mixture by preparative HPLC. For product 
verification high-resolution mass spectrometry (HR/MS), 
1H NMR, 13C NMR, HMBC, COSY, and HSQC were per-
formed (for additional information and results see Addi-
tional file 6).
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Cell toxicity tests
Cell growth assay
The effect of different eugenol 1 concentrations on cell 
growth of E.  coli OverExpress C41(DE3) cells carry-
ing pACYCtac_psvao and pET16b_cgl1 was monitored. 
400  ml  TB-medium were inoculated with 4  ml of an 
overnight culture and incubated at 37  °C, 180  rpm to 
an OD600 of 0.6. Cells were harvested by centrifugation, 
resuspended in TB-medium adjusting an OD600 = 0.6, 
and split. Different concentrations of eugenol 1 (0, 1, 
2.5, 5,  or 10  mM) and 2  % (v/v) DMSO were added. 
Cells were incubated at 37 °C, 180 rpm and cell growth 
was analysed for additional 18  h by measuring the 
OD600.
Cell viability assay
Viability of resting E. coli cells during biotransformations 
was assayed as follows: 40 µl of the cell suspension was 
withdrawn immediately after eugenol 1 addition, as well 
as after 24  h reaction time. The samples were diluted 
and plated on LB-agar-plates containing 100  µg  ml−1 
ampicillin and 50  µg  ml−1 streptomycin. After incuba-
tion at 37 °C over night colony forming units (CFU) were 
counted.
Reaction analysis by GC/MS, LC/MS, and HPLC
GC/MS analysis was performed as described previously 
[17].
Non-chiral LC/MS measurements were performed 
on a LC/MS-2020 (Shimadzu, Duisburg, Germany) 
equipped with a Chromolith® Performance RP-18e col-
umn (100  ×  4.6  mm, Merck, Darmstadt, Germany). A 
solvent gradient of methanol and 0.1 % formic acid at a 
flow rate of 0.5  ml  min−1 was applied as follows: start-
ing from 20 to 35 % methanol in 5 min, hold for 5 min, 
increase to 70 % methanol within 15 min, then to 90 % 
methanol within 1 s, hold for 1 min, re-equilibration with 
20  % methanol. UV/Vis spectra were monitored in the 
range between 190–800  nm. The interface temperature 
was 350 °C, the desolvation line temperature was 275 °C, 
and the heat block temperature was 400 °C. The nebuliz-
ing gas flow and the drying gas flow were set to 1.5 and 
15 l min−1, respectively.
For determination of the enantiomeric composi-
tion of pinoresinol 3, lariciresinol 4, and secoisola-
riciresinol 5 reaction mixtures were analysed by chiral 
HPLC (Shimadzu, Duisburg, Germany) equipped 
with a CHIRALPAK®IB column (250 × 4.6 mm, Chi-
ral Technologies Europe, Illkirch Cedex, France). 
The solvents n-hexane/ethanol were used under iso-
cratic conditions (pinoresinol 3: 50/50; lariciresinol 4: 
80/20, secoisolariciresinol 5: 75/25) at a flow rate of 
0.7 ml min−1.
Product isolation and identification
Pinoresinol 3 and lariciresinol 4 were purified by pre-
parative HPLC equipped with a MultoHigh 100 Si-10  µ 
column (250 × 10 mm, pore size 100 Å, 10 µm particle 
size, CS-Chromatographie Service, Langerwehe, Ger-
many). A solvent gradient of n-heptane and ethanol at a 
flow rate of 7.5 ml min−1 was applied as follows: starting 
from 10 to 39 % ethanol in 12.5 min, increase to 90 % eth-
anol within 1 s, hold for 1 min, re-equilibration with 10 % 
ethanol.
Product identification was performed by NMR and 
HR/MS as described in the Additional file 6.
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Additional file 5. HPLC chromatograms of enantiomeric separations 
of reaction products. a Application of AtPrR2; b application of FiPLR. 
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